Abcam (LON:ABC)‘s stock had its “hold” rating reiterated by investment analysts at Peel Hunt in a research note issued to investors on Thursday.
A number of other equities analysts have also commented on ABC. Berenberg Bank reiterated a “hold” rating and set a GBX 1,230 ($16.07) price target on shares of Abcam in a report on Thursday, July 12th. Numis Securities reiterated a “hold” rating and set a GBX 1,380 ($18.03) price target on shares of Abcam in a report on Thursday, July 12th.
Shares of LON:ABC opened at GBX 1,200 ($15.68) on Thursday. Abcam has a 52 week low of GBX 9.73 ($0.13) and a 52 week high of GBX 1,290 ($16.86).
Abcam Company Profile
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.
Recommended Story: What is a stock buyback?
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.